Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

ClinicalTrials.gov ID: NCT02547220

Public ClinicalTrials.gov record NCT02547220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients

Study identification

NCT ID
NCT02547220
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
39 participants

Conditions and interventions

Interventions

  • Cinryze® Biological
  • Placebo Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2016
Primary completion
May 30, 2019
Completion
May 30, 2019
Last update posted
Jul 12, 2020

2016 – 2019

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
Kidney Transplant Research Office at UCLA Los Angeles California 90024
Keck School of Medicine at USC Los Angeles California 90033
University of California San Francisco San Francisco California 94110
University Of Colorado School Of Medicine Aurora Colorado 80045
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20057
Jackson Memorial Hospital Miami Florida 33136
Florida Hospital Transplant Institute Orlando Florida 32804
Piedmont Hospital Atlanta Georgia 30309
Northwestern Memorial Hospital Chicago Illinois 60611
University of Maryland Medical Center Baltimore Maryland 21201
Johns Hopkins University Baltimore Maryland 21287
Brigham and Womens Hospital Boston Massachusetts 02115
University of Minnesota Minneapolis Minnesota 55414
Washington University School of Medicine St Louis Missouri 63110
Saint Barnabas Medical Center Livingston New Jersey 07039
Mount Sinai Hospital New York New York 10029
Columbia University Medical Center New York New York 10032
New York Presbyterian Hospital - Weill-Cornell New York New York 10065
NYU Longone Medical Center White Plains New York 10605
University of Cincinnati Cincinnati Ohio 45220
Cleveland Clinic Cleveland Ohio 44195
Ohio State University Medical Center Columbus Ohio 43210
INTEGRIS Nazih Zuhdi Transplant Institute Oklahoma City Oklahoma 73112
University of Pittsburgh Medical Center Monroeville Pennsylvania 15146
University of Pennsylvania Health System Philadelphia Pennsylvania 19104
Vanderbilt University Medical Center Nashville Tennessee 37204
Baylor All Saints Medical Center Fort Worth Texas 76104
Houston Methodist Hospital Houston Texas 77030
University of Utah Health Sciences Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02547220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02547220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →